Link to the full source article
RSS feed source: National Institute of Health
Notice of Clarification of Requirements and Non-responsive Activities in RFA-RM-24-012, In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed)
The purpose of this notice is to clarify the requirements and non-responsive activities in RFA-RM-24-012
Part 2. Section I. Notice of Funding Opportunity Description
Requirements
Currently reads:
This NOFO will support projects that develop novel in vivo optical imaging utilizing light as the imaging modality. Here, light is defined as radiation ranging from ultraviolet to infrared on the electromagnetic spectrum. The imaging technique must be capable of providing unique in vivo imaging information from live tissues using non- or minimally invasive technical strategies. Development of the device must first demonstrate a significant increase in tissue depth non-invasively; following development, the device may be used in applications that are non-invasive, minimally invasive, or in surgical settings. The advancement, when compared
Click this link to continue reading the article on the source website.